What matters to patients and clinicians when discussing the impact of cancer medicines on health-related quality of life? Consensus-based mixed methods approach in prostate cancer

por Dunlop, Emma, Ferguson, Aimee, Mueller, Tanja, Baillie, Kelly, Clarke, Julie, Laskey, Jennifer, Kurdi, Amanj, Wu, Olivia, Jones, Rob, Glen, Hilary, Bennie, Marion
Publicado 2021

Healthcare Costs for Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide

por Rana, Dikshyanta, Geue, Claudia, Baillie, Kelly, Pan, Jiafeng, Mueller, Tanja, Laskey, Jennifer, Bennie, Marion, Clarke, Julie, Jones, Robert J., Brown, Ailsa, Wu, Olivia
Publicado 2021

Use of record linkage to evaluate treatment outcomes and trial eligibility in a real‐world metastatic prostate cancer population in Scotland

por Baillie, Kelly, Mueller, Tanja, Pan, Jiafeng, Laskey, Jennifer, Bennie, Marion, Crearie, Christine, Kavanagh, Kimberley, Alvarez‐Madrazo, Samantha, Morrison, David, Clarke, Julie, Keel, Aileen, Cameron, David, Wu, Olivia, Kurdi, Amanj, Jones, Robert J.
Publicado 2020